![](https://mayan-lab.com/wp-content/uploads/2022/08/Logo-CellCOM-01.png)
Welcome
Welcome to the website of the CellCOM Research Group. Our group is a translational and clinical research group within the Center for Research in Nanomaterials and Biomedicine (CINBIO). Our approaches combine in vitro, ex vivo and in vivo models to conduct pre-clinical studies in age-related diseases and cancer. Our group is a multidisciplinary team that includes basic scientists (predoctoral, postdoctoral fellows and technicians) and clinical researchers such as pathologists, dermatologists, radiologists and surgeons.
Our aims are to understand the physiopathology of connexin-linked diseases (cancer, inflammation, tissue degeneration), to design molecules and new drugs that modulate the activity of specific targets and to identify novel markers of disease prevention, diagnosis and disease management.
We are focused on understanding the role of connexins and pannexins in osteoarthritis, skin wound healing in oncological patients, metastasis and resistance to targeted cancer therapies and immunotherapies. Our final goal is to identify effective therapeutic targets to design specific and successful therapeutic approaches to treat these disorders.
Follow us on Twitter to stay updated on news
Latest news
Press and Disclosures
December 2016 Link International Young Investigator Meeting 2016 http://www.iyimeeting2016.com/Inicio.html …
New paper published in Biochimica et Biophysica Acta (BBA) – Molecular Cell Research
Feb 2017 This research work was performed in collaboration with…
New results published in the MOLECULAR & CELLULAR PROTEOMICS
This research work was led by Maria Mayan, performed in…
We got the first position for the all areas of biological science and biomedicine
June 2016 We got the first position for the all…